March 13, 2018
Christopher Evans, professor and chair of the UC Davis Department of Urology and president of the Society of Urologic Oncology, will receive the Platinum Award at the International Friendship Dinner on Sunday, March 18 during the 33rd annual European Association of Urology (EAU) meeting in Copenhagen, Denmark.
March 9, 2018
Primo “Lucky” Lara, Jr. will become the new deputy chair of SWOG, a research organization of more than 12,000 people at over 1,000 hospitals and clinics that designs and conducts publicly funded cancer clinical trials and that represents a major force cancer advances worldwide.
March 8, 2018
Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.
February 9, 2018
Adolescent and young adult cancer survivors who are African American, poor or have public or no health insurance are far more likely to suffer from coronary artery disease, heart failure or stroke later in life than non-Hispanic white cancer survivors.
January 3, 2018
In a commentary published today in the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse animal models.
December 21, 2017
A team of UC Davis investigators has been awarded a $1.2 million grant to examine a common virus and its effects on immune system function after stem cell transplantation.
December 19, 2017
Human and veterinary researchers at UC Davis and other institutions have shown that enhanced natural killer (NK) immune cells, combined with radiation therapy, can be effective against spontaneous osteosarcoma (bone cancer) in dogs. The research showed these NK cells homed in on cancer and reduced metastasis in the treated dogs, offering a potential immunotherapy against solid tumors. The study was published today in the Journal for Immunotherapy of Cancer.
November 17, 2017
Giving bad news is never easy, especially when it’s life or death. But when an oncologist delivers a poor prognosis to a cancer patient, does it harm their relationship? Some research studies have suggested it can.
November 7, 2017
For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives. But through new discoveries at the genetic level, the personal nature of cancer will eventually be what helps to beat it.
October 25, 2017
Participating in a brief intervention delivered by their peers in community settings can help reduce smoking among youth and young adults, a new study from a team of tobacco-cessation researchers shows.
October 24, 2017
October 20, 2017
UC Davis has received its first National Cancer Institute (NCI) Moonshot grant ̶ $2.5 million over five years ̶ to explore immunotherapy treatments for dogs who develop melanoma and osteosarcoma and that may one day benefit humans, as well.
October 19, 2017
Members of the UC Davis Comprehensive Cancer Center lung cancer treatment team will present at WCLC 2017, a one-day conference on Saturday, Nov. 11, from 7 a.m. to 4 p.m. in San Francisco. Presenters will share the latest lung cancer and other thoracic malignancy advances highlighted at the recent 18th Annual World Conference on Lung Cancer in Japan.
October 6, 2017
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics, has received a $1.5 million award from the National Institutes of Health to advance the development of “smart” immune cells for therapies to treat cancer and other diseases. The five-year NIH Director’s New Innovator Award aims to provide new insight into how to engineer immune cells to control their recruitment and response to tumors.
October 3, 2017
UC Davis Children's Hospital, UC Davis Comprehensive Cancer Center and the UC Davis Genome Center are hosting the 2017-2018 Human Genomics Seminar Series, a monthly series focusing on genomic medicine topics, led by UC Davis faculty. Seminars will be held the first Wednesday of every month at noon at the Center for Health and Technology, room 1341.
September 28, 2017
The California Institute for Regenerative Medicine today awarded a nearly $8 million grant to University of California, Davis, stem cell researchers to launch a special clinical trials program in Sacramento to accelerate the therapeutic development and delivery of stem cell therapies in human patients.
September 27, 2017
UC Davis researchers, led by Julie Sutcliffe, have received a $3.3 million grant from the National Institutes of Health to advance efforts to diagnose pancreatic cancer before it spreads.
August 30, 2017
UC Davis stem cell scientist Paul Knoepfler has been awarded a second $250,000 grant for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.
August 18, 2017
UC Davis researchers have shown that radiation therapy before surgery improves overall survival for patients with soft tissue sarcomas. This pre-surgical, or neoadjuvant, radiotherapy allows surgeons to get better margins around tumors and remove even microscopic cancer tissue more often. The study was published recently in the Annals of Surgical Oncology.
August 8, 2017
U.S. News & World Report, which annually recognizes hospitals that excel in treating patients with serious and challenging injuries and illnesses, has again ranked UC Davis Medical Center as one of the nation's best hospitals.
August 1, 2017
Shin-Ping Tu, a national expert on improving health care delivery and cross-cultural medical care, has become chief of the Division of General Medicine at UC Davis Health. She leads a team of nearly 40 physicians who provide comprehensive treatment to adults and research innovative ways to advance patient care, train physicians and improve health policy.
July 26, 2017
Sorting out when or whether to get mammograms can be perplexing for any woman, and a health provider’s advice may not settle the matter. That’s because even experts disagree about when screening mammography is appropriate and for whom.
June 20, 2017
UC Davis Health welcomes 145 migrant high school students Sunday, June 25 for a day of tours, talks and opportunities to learn more about medical science from students, fellows and faculty.
June 6, 2017
With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.
June 2, 2017
David R. Gandara, professor and director of thoracic oncology at UC Davis Comprehensive Cancer Center, has been named a “Giant of Cancer Care” in lung cancer by OncLive in recognition of his work to advance the field of oncology through his contributions in research and clinical practice.
May 24, 2017
UC Davis has signed a licensing agreement providing Isotropic Imaging Corporation the rights to commercialize a novel computed tomography (CT) scanner that has the potential to improve breast cancer detection and positively impact women’s health.
May 10, 2017
Former UC Davis Medical Center Chief Executive Officer Robert E. Chason passed away on May 8, 2017, following a brief illness. He was 73.
April 25, 2017
Sean Collins, assistant professor of microbiology and molecular genetics in the UC Davis College of Biological Sciences, has received a Kimmel Scholar Award from the Sidney Kimmel Foundation.
April 25, 2017
Patients in California hospitals were more likely to die within 60 days of being diagnosed with acute myeloid leukemia – a cancer of the blood and bone marrow – if they were unmarried, lived in a less-affluent neighborhood or lacked health insurance. The UC Davis study also found that patients treated at a National Cancer Institute (NCI)-designated cancer center were more likely to survive.
April 20, 2017
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.